Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00976963 · ClinicalTrials.gov registry record · NA
Single Dose Monurol for Treatment of Acute Cystitis
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT00976963 is a NA study that has completed, run by University of Washington. The registered enrollment target is 300 participants.
The verdict
NCT00976963, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
Urinary tract infecton (UTI) is a very common problem in young healthy women, afflicting approximately one-half of women by their late 20's. One of the most common antibiotics used to treat UTIs is Trimethoprim-Sulfamethoxazole (TMP-SMX), usually for total of three days. However, concerns about increased antibiotic resistance have led to increased interest in studying other antibiotics for UTI. An alternative antibiotic which is also FDA approved for the treatment of UTIs is fosfomycin (Monurol). The effectiveness of fosfomycin in curing UTIs when given as a single dose is not well studied. The purpose of this research study is to determine what the cure rates are with a single dose of fosfomycin versus the more standard 3-day course of TMP-SMX.
Interventions
- DRUG TMP/SMX
- DRUG Fosfomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2009-09-17 |
| Est. Completion | 2016-12-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00976963
The ClinicalTrials.gov registry entry for NCT00976963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TMP/SMX is the first listed.
NCT00976963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00976963 about?
NCT00976963 is a clinical study titled "Single Dose Monurol for Treatment of Acute Cystitis". Urinary tract infecton (UTI) is a very common problem in young healthy women, afflicting approximately one-half of women by their late 20's. One of the most common antibiotics used to treat UTIs is Trimethoprim-Sulfamethoxazole (TMP-SMX), usually for total of three days. However, concerns about incr...
What is the current status of trial NCT00976963?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2009-09-17. Estimated completion is 2016-12-27.
What interventions are being tested in trial NCT00976963?
The interventions under investigation include: TMP/SMX (DRUG), Fosfomycin (DRUG).
Who is sponsoring clinical trial NCT00976963?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.